Talis Biomedical (TLIS) SEC Filings & 10K Form → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free TLIS Stock Alerts $9.26 +0.05 (+0.54%) (As of 05/9/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Recent Talis Biomedical SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/08/20247:04 AMTalis Biomedical (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/11/20243:53 PMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/31/202411:15 PMTalis Biomedical (Filer)Form EFFECT03/28/20248:08 AMTalis Biomedical (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/26/20243:39 PMTalis Biomedical (Filer)Form POS AM02/14/20243:47 PMGREENLIGHT CAPITAL INC (Filed by)Talis Biomedical (Subject)Form SC 13G/A09/01/20234:00 PMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/02/20237:17 AMLukowiak Andrew A (Reporting)Talis Biomedical (Issuer)Form 3Initial statement of beneficial ownership of securities 08/02/20237:18 AMLukowiak Andrew A (Reporting)Talis Biomedical (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/02/20237:15 AMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/27/20237:30 AMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/24/20237:41 AMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/18/20234:37 PMMarkovich Rebecca (Reporting)Talis Biomedical (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/05/20237:10 AMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/23/20237:32 AMDreismann Heinrich (Reporting)Talis Biomedical (Issuer)Form 3Initial statement of beneficial ownership of securities 05/23/20237:33 AMDreismann Heinrich (Reporting)Talis Biomedical (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/23/20237:15 AMTalis Biomedical (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: AXDX 10K Form HLTH 10K Form TBIO 10K Form PRPO 10K Form OMIC 10K Form RPID 10K Form LUCD 10K Form BNGO 10K Form CCLD 10K Form QTI 10K Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:TLIS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
